Development of cochlear implants

By Parth10
  • Surgery, before implants were developed

    Microsurgical techniques and stapes surgery made the idea of surgical implants possible. An electrode was directly applied to the acoutic nerve of a deaf person and the nerve stimulated by electricity.
  • Period: to

    Cochlear implant Development

  • Circuit development to aid cochlear implant development

    Advances in cardiac pacemakers increased knowledge of biocomaptible materials, insulation of elctrodes and the effects of electrical simulation. As a spin off of space research, smaller and more powefull electrical circuits were developed.
  • Further cochlear development started

    Inspired by his close relationship with his deaf father, Graeme Clark begins researching the possibilities of an electronic implantable hearing device. Graeme Clark began researching possibilities of an elctronic implantable hearing device.
  • First multi-channel impalnt was made

    cochlear implant projects were trailled in 1976 Professor Graeme Clark of the universoty of melbourne made the first multi-channel implant. he is considered to be the fatheer of cochlear impants.
  • New designs were being developed as well as products being tested

    Professor Graeme Clark receives research grant for "The Development of a Hearing Prosthesis". Professor Clark, determined to discover a way to get the electrode placed securely in the inner ear – finds a solution by experimenting with a blade of grass and a small turban shell on the Minnamurra Beach in New South Wales, Australia. He also discovers the importance of a graded stiffness in the design of the electrode. Mona Andersson was the first recipient of a bone conduction hearing implant.
  • Circuit diagram for the Mastermos silicon chip design made

    Engineers Jim Patrick (left) and Ian Forster (right) present the circuit diagram for the Mastermos silicon chip designed to provide circuitry for one of the ten stimulus channels of the first bionic ear.
  • First receipent experimented with was successful

    Rod Saunders was the world's first cochlear implant recipient to show the benefit of multi-channel stimulation. After his sound processor was turned on, Rod excitedly jumped up and saluted, indicating that he could hear again.
  • First cochlear recipient

    Rod Saunders was the world's first cochlear implant recipient to show the benefit of multi-channel stimulation. After his sound processor was turned on, Rod excitedly jumped up and saluted, indicating that he could hear.
  • New similar device used by Rod Saunders and more devices to come

    Rod Saunders used a portable speech processor: (PSP) and handheld microphone this year after the success last year. A medical device group, Nucleus, becomes interested in the potential of Professor Clark’s work. Eventually, Nucleus and Cochlear (the company was officially formed later during the early 1980’s) and the Australian Government would partner to develop a commercially available implant and bring it to market. We know it today as the Nucleus® multi-channel cochlear implant.
  • Second recipient, George Watson

    Portable speech processor with magnet-less headset is created. George Watson, second recipient, spends time in programming with Joe Tong.
  • Paul Trainor, developer Nucleus implant

    Paul Trainor is given AU$4million to start commercial development of the multi-channel cochlear implant. Trainor was the owner of the Nucleus group, which included Telectronics, an Australian heart pacemaker firm. Trainor directed the team of expert bio-engineers that would ultimately bring the Nucleus multi-channel cochlear implant to commercial market.
  • Rod Saunders, processor upgrade

    In 1982, three years after receiving his cochlear implant, Rod Saunders receives a new wearable speech processor (WSP).
  • First Nucleus implant

    The first commercial Nucleus implant (the Nucleus CI22) was implanted at the University of Melbourne. The recipient was Graham Carrick, aged 37 years. The ability to hear again marked a life changing moment for Graham, providing him with confidence and hope.
  • Cochlear Americas office established

    A small team establishes the Americas office outside Denver, Colorado.
  • FDA approves Nucleus implant system

    Nucleus established as the first multi-channel cochlear implant system to obtain clearance from the FDA for use by profoundly deaf adults 18 and over. The Nucleus Mini22 implant with the WSP (Wearable Speech Processor) was the first multi-channel device to receive FDA pre-market application approval.
  • First two paediatric implant recipients

    The first two research paediatric cochlear implant procedures take place at the Royal Victorian Eye and Ear Hospital. Professor Clark keeps company with the first two paediatric cochlear implant recipients; Scott Smith (10 years) - first child - and Bryn Davies (five years) -- second child 1985. Clinical trials for cochlear implant for children begin in the US.
  • First paediatric Nucleus recipient

    Holly McDonell, at the age of four, is the first paediatric recipient of a commercial Nucleus cochlear implant. She still has her original implant and has had five sound processor upgrades.
  • New mini speech processor introduced

    Nucleus 22 recipients are upgraded from their original WSP to the smaller mini speech processor (MSP). New processor is much smaller and lighter than the WSP; it has the MPEAK speech coding strategy, providing improved performance; and the smaller size makes it more suitable for children.
  • US FDA approves Nucleus Cochlear Implant system for children age 2-17

    The US FDA approves the Nucleus Cochlear Implant System for children aged 2 to 17 years, the first cochlear implant to be approved by a regulatory body for use in children. Increasing number of impants were performed. many on children.
  • speech proccessor design improvments

    Huge improvements in speech processor design and sound quality users. this meant patients could recognise speech and music patterns more realisticly. cochlear implants consist of a 22 channel stimulator in a titanium capsule with platium electrodes.
  • 10,000 recipient mark

    Cochlear celebrates the 10,000th Nucleus recipient. Spectra processor upgrade for Nucleus 22 users. This utilizes SPEAK, an improved speech coding strategy providing fuller, richer, more natural sound.
  • Product innovation

    The first implant capable of performing Neural Response Telemetry (NRT™), used to provide an objective measurement of the hearing nerve’s response to electrical stimulation (NRT). This allows medical professionals to test the hearing nerve to make sure it is functioning properly.
  • Further product inovation

    SPrint – the powerful bodyworn speech processor is introduced. SPrint™ technology is based on a powerful Digital Signal Processor (DSP). The first MRI-safe implant up to 1.5 tesla is introduced.
  • BTE inovation

    The first multi-channel BTE processor introduced – the ESPrit. A speech processor worn entirely behind the ear, freeing recipients from long cables and extra components. This innovation eventually benefits the first cochlear implant recipients, giving them option of the smaller behind the ear model.
  • Contour

    Nucleus 24 cochlear implant released. The new implant offers technicaladvancements including an electrode designed to provide more directstimulation. Also includes the removable magnet for MRI and the Nucleusstandard titanium casing. 20,000th person receives a Nucleus cochlear implant.
  • ACE speech coding strategy introduced

    Nucleus ACE speech coding strategy is developed and introduced by the engineers at Cochlear. ACE is designed to customise sounds by combining the benefits of pitch information of the SPEAK strategy, with the higher rates of stimulation offered by the CIS strategy. The result is an advanced strategy that can be customised to meet each person's hearing needs.
  • The ESPrit™ 22 BTE speech processor released

    The ESPrit™ 22 BTE speech processor released
    The fourth upgrade for Nucleus 22 recipients. Sets industry standard of a Lifetime Commitment in providing a BTE option for recipients implanted many years before.
  • Baha Softband recipient

    Marije Meijer, at age four months, was one of the first Baha Softband [bone conduction hearing implant] recipients. The Baha Softband received FDA approval in 2002.
  • 30,000 Nucleus recipients mark

    Cochlear celebrates their 30,000th Nucleus recipient.
  • Espirit 3g and behind the ear speech processor is introduced

    http://dev.nsta.org/evwebs/715n/history-of-cochlear-implant.html Espirit 3g is introduced and the behind the ear speech processer is introduced which is the first speech processer with and in built telecoil, making phone use more accessible.
  • Baha® system approved to treat single-sided deafness in the USA

    “Baha makes it effortless to hear at work” says Anne-Marie. “Now, since I have no ‘bad side’ I’m able to be more active and involved in discussions. And I never miss a joke!”.
  • Nucleaus freedom

    Nucleaus freedom
    Nucleaus freedom is introduced, the fourth generation cochlear implant and speech processing technology. Nucleus® Freedom® system released. Offers input processing technologies designed to emulate natural hearing and is the industry’s first water resistant sound processor.
  • Baha Divino® released

    Baha Divino® released
    Advanced digital sound processing and built in directional microphone for focused listening.
  • Baha Intenso® released

     Baha Intenso® released
    Advanced digital signal processing, extra power and reduced size.
  • Nucleus Freedom available for Nucleus 22 implant recipients

     Nucleus Freedom available for Nucleus 22 implant recipients
    Freedom is compatible with all previous Nucleus generation implants, giving recipients access to the latest hearing innovations.
  • Cochlear Hybrid™

    Cochlear Hybrid™
    Combines both cochlear implant and hearing aid technologies to overcome high frequency loss. High frequency sounds are sent to the cochlea via the implant. Simultaneously, low frequency sounds are amplified and sent through the ear canal via the acoustic (hearing aid) component.
  • Hybrid L24 Implant

     Hybrid L24 Implant
    Specifically designed for sufferers of high frequency hearing loss. The Hybrid implant bypasses damaged hair cells in the high frequency hearing zone to provide recipients access to high frequency sounds which are vital for understanding speech.
  • Cochlear Nucleus 5 System released

    Cochlear Nucleus 5 System released
    Latest cochlear implant system, introducing the CP810 sound processor and the first ever remote assistant.
  • Cochlear Baha 3 released

    Cochlear Baha 3 released
    Baha BP100 Sound Processor more than 25% improved speech understanding in noise compared to previous Baha sound processors.
  • Oldest cochlear implant recipient at 102 years old

    Oldest cochlear implant recipient at 102 years old
    In 1991, at age 83, Jack Walley received his Nucleus® 22 implant at the University Hospital Birmingham, UK.
  • Cochlear Baha 3 BI300 implant

    Cochlear Baha 3 BI300 implant
    First bone conduction implant to utilise an advanced surface technology (TiOblast™), which can reduce the time it takes for the implant to bond with bone. This allows the recipient to access sound sooner.